GNAK 50 mg/ml otopina za infuziju
| Name | GNAK 50 mg/ml otopina za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-735820593 |
| Active Substance | glukoza hidrat natrijev klorid natrijev acetat trihidrat kalijev klorid magnezijev klorid heksahidrat |
| Composition | 1000 ml otopine za infuziju sadrži 50 g glukoze (u obliku glukoza hidrata),1 g natrijevog klorida, 3,13 g natrijevog acetat trihidrata, 1,50 g kalijevog klorida i 0,30 g magnezijevog klorid heksahidrata |
| Pharmaceutical Form | otopina za infuziju |
| Manufacturer | Bieffe Medital S.A., Sabinanigo (Huesca), Španjolska |
| Marketing Authorisation Holder | Baxter d.o.o., Letališka cesta 29A, Ljubljana, Slovenija |
| Marketing Authorisation Date | 18.09.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/76 |
| Registration Number | 381-12-01/70-23-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | B05BB02 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
